MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
RS-61443--a new, potent immunosuppressive agent.
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
Quinobene, a new potent anti-HIV agent.
A potent new beta2-adrenoceptor blocking agent.
Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.
Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses.
Preclinical evaluation of DO3A-Act-AQ: a polyazamacrocyclic monomeric anthraquinone derivative as a theranostic agent.
Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus™.
The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents.
Potent immunosuppressive effects of heterologous antiimmunoglobulin serum.
Physiologic evaluation of a new antihypertensive agent: prazosin HCl.
Development and mechanism investigation of a new piperlongumine derivative as a potent anti-inflammatory agent.
Preclinical evaluation and molecular docking of 2,5-di-tert-butyl-1,4-benzoquinone (DTBBQ) from Streptomyces sp. VITVSK1 as a potent antibacterial agent.
Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structure.
Bacterial flagellin-a potent immunomodulatory agent.
beta-endorphin is a potent analgesic agent.
Evaluation of naphthoquinones identified the acetylated isolapachol as a potent and selective antiplasmodium agent.
2,3,2-tetramine--a potent cupruretic agent.
Letter: Linoleic acid as an immunosuppressive agent.
Natural honey: a new and potent anti-angiogenic agent in the air-pouch model of inflammation.
Phainanoids A-F, a new class of potent immunosuppressive triterpenoids with an unprecedented carbon skeleton from Phyllanthus hainanensis.
p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.
Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects.
Preclinical evaluation of a new potent immunosuppressive agent, rapamycin.
Since individual immunosuppressive agents display pleiotropic arrays of nonimmunologic toxic complications when used at therapeutic concentrations, sy...
791KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
RS-61443--a new, potent immunosuppressive agent.
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
Quinobene, a new potent anti-HIV agent.
A potent new beta2-adrenoceptor blocking agent.
Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.
Biological evaluation of subglutinol a as a novel immunosuppressive agent for inflammation intervention.
Effects of a new immunosuppressive agent, FK 506, on the efferent limb of the immune responses.
Preclinical evaluation of DO3A-Act-AQ: a polyazamacrocyclic monomeric anthraquinone derivative as a theranostic agent.
Preclinical pharmacokinetic studies of 3-deazaneplanocin A, a potent epigenetic anticancer agent, and its human pharmacokinetic prediction using GastroPlus™.
The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms